Overview
The purpose of this study is to evaluate the efficacy and safety of co-administration of AD-227A and AD-227B in patients with essential hypertension
Description
Essential Hypertension
Eligibility
Inclusion Criteria:
- Signed informed consent
- Patients with Essential Hypertension
- Other inclusions applied
Exclusion Criteria:
- Patient with Secondary Hypertension
- Other exclusions applied